25 weeks, the rats received s.c. injections of T4 (0.2 jug kg-') in depot form every other day until the end of the experiment in Week 52. This long-term treatment with T4 significantly increased the incidence of gastric cancers in Week 52. However, it did not influence the histological type of the gastric cancers. It also caused significant increases in the labelling indices of the fundic and antral epithelial cells. These findings indicate that T4 enhances the development of gastric cancers, and that its effect may be related to its effect in increasing proliferation of gastric epithelial cells.
Summary The affects of L-thyroxine (T4) on the incidence and histology of gastric cancers induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) , and on the labelling index of gastric mucosal epithelial cells were investigated in Wistar rats. After oral treatment with MNNG for 25 weeks, the rats received s.c. injections of T4 (0.2 jug kg-') in depot form every other day until the end of the experiment in Week 52. This long-term treatment with T4 significantly increased the incidence of gastric cancers in Week 52. However, it did not influence the histological type of the gastric cancers. It also caused significant increases in the labelling indices of the fundic and antral epithelial cells. These findings indicate that T4 enhances the development of gastric cancers, and that its effect may be related to its effect in increasing proliferation of gastric epithelial cells.
Thyroid hormones have important regulatory roles in the morphology and biochemistry of gastrointestinal mucosal cells (Hernandez et al., 1988) . Long-term T4 administration increased the mitotic activity of the fundic 'stem' cells of the stomach and basal and secretagogue-stimulated acid secretion via its effect on parietal cell mass (Adeniyi & Olowookorun, 1989) . We recently found that prolonged administration of T4 significantly increased the incidence of rat colon tumours induced by azoxymethane (Iishi et al., 1992) . These findings suggest that T4 might influence gastric carcinogenesis. Therefore, in the present work, we examined the effect of treatment of rats with T4 on the development of gastric cancers in rats.
Materials and methods

Animals
Sixty 6-week-old male Wistar rats (SLC, Shizuoka, Japan) were used in this study. They were housed in stainless steel suspended wire mesh cages, under controlled environmental conditions of 12 h light and 12 h darkness, 30-50% humidity, and 21-22'C. Each rat was given standard laboratory chow (Oriental Yeast, Tokyo, Japan) (Stefanini et al., 1967) for histological examination. The fixed stomach was cut into longitudinal, 3 mm wide strips. The specimens were embedded in paraffin, and 5 gm thick serial sections were stained with hematoxylin and eosin. Sections were examined without knowledge of which group they were from.
Classification ofgastric cancers
Histologically, adenocarcinomas were defined as lesions in which neoplastic cells had penetrated the muscularis mucosae to the submucosa or deeper layers. Adenocarcinomas were classified as very well-differentiated, well-differentiated, and poorly differentiated, as reported previously (Tatsuta et al., 1988b (Gratzner, 1982; Morstyn et al., 1983 (Siegel, 1956) . Other results were all analysed by one-way analysis of variance with Dunn's multiple comparison (Snedecor & Cochran, 1967; Miller, 1966 showed significantly higher labelling indices and increased number of cells in the zone of proliferating cells in both the fundic and antral mucosa than Group 1 (olive oil). Table III shows that at both times, administration of T4 significantly increased the serum levels of T4 and T3.
Discussion
In the present work, we found that T4 enhanced gastric carcinogenesis induced by MNNG in Wistar rats. Long-term s.c. administration of T4 in depot form significantly increased the incidence of gastric cancer, but had no influence on their histological type at autopsy in Week 52. aFor explanation of treatments, see Table I . bSignificance of difference from the value of Group 1 at P <0.001.
The mechanism of this effect is not known, but three possible explanations may be considered. One is an immunomodulatory role of T4. Thyroid hormones have immunostimulatory (Pierpaoli et al., 1969; Bachman & Marshaly, 1986) and immunosuppressive (Gupta et al., 1983) effects on the lymphocyte population. As observed after other endocrine treatments, e.g., with estrogen or cortisone in mice (Milisauskas et al., 1983; Hochman & Cudkowicz, 1979) , the inhibition of natural killer cell activity caused by long-term T4 administration might be ascribed to the induction of suppressor cells.
A second possibility is an influence of T4 on the secretion and/or synthesis of regulatory peptides such as epidermal growth factor (EGF) and somatostatin. Walker et al. (1981) found that 5 and 10 days treatments with T4 significantly increased the EGF concentration in the submaxillary gland of mice. EGF is a well characterised polypeptide that exhibits mitogenic effects on a wide range of cell types after binding to specific transmembrane receptors (Cohen, 1983) . As EGF can stimulate mucosal growth throughout the gastrointestinal tract, it has been suggested as playing a role in gastrointestinal carcinogenesis. Yasui et al. (1990) found that prolonged s.c. administration of EGF significantly increased the incidence of gastric cancers induced by MNNG. A high level of T4 was shown to increase the secretion and hypothalamic content of somatostatin in vivo and in vitro (Berelowitz et al., 1980) . We found previously that prolonged s.c. administration of somatostatin significantly increased the incidence and number of gastric cancers (Tatsuta et al., 1989) .
A third possibility is an acceleration of cell proliferation by T4. de Launoit and Kiss (1989) found that T4 dramatically stimulated the cell division by MXT (mouse) and MCF-7 (human) mammary cancer cell lines. In mammary tumorigenesis, T4 may exert its stimulatory effect at the level of the nuclear chromatin receptors (Oppenheimer, 1979 The present study showed that T4 administration increased the yield of gastric cancers after MNNG treatment, presumably by acting as a non-genotoxic growth stimulator for the mucosal cells. Watanabe et al. (1992) found that oral administration of NaCl after MNNG pretreatment significantly increased the incidence of gastric cancers and that it also significantly increased the height of the pyloric mucosa. Many investigators (Takahashi et al., 1986; Tatsuta et al., 1988a; Kobori et al., 1984) have indicated that enhancing effects on gastric carcinogenesis may be related to stimulation of cell proliferation and elongation of the mucosa. These findings suggest that a non-genotoxic component increases tumour yield when administered subsequent to a genotoxic agent.
Abbreviations: MNNG, N-methyl-N'-nitro-N-nitrosoguanidine; BrdU, bromodeoxyuridine; T4, L-thyroxine; T3, triiodothyronine; EGF, epidermal growth factor.
